Correction to “Enteropathic SAPHO Syndrome in Ulcerative Colitis Responsive to Bisphosphonates”
First published: 09 July 2025
J. Phillipps, S. Mumtaz, J. Valecha, et al., “Enteropathic SAPHO Syndrome in Ulcerative Colitis Responsive to Bisphosphonates,” Case Reports in Rheumatology, 2024, https://doi.org/10.1155/2024/3558853.
In the article, there is an error in the stated dosage of zoledronic acid given to the patient. The correct dosage is 5 milligrams of zoledronic acid.
The authors apologize for this error.
